A close connection between research and the clinic

NIBR takes a unique approach to pharmaceutical research. At the earliest stages, research priorities are determined by patient need and disease understanding.

• At NIBR, physician-scientists are breaking down the boundaries between research and clinical practice.
• We use Proof-of-Concept clinical trials (small-scale studies used to get an early read on a drug’s safety and effectiveness) to help us to find and advance the most promising drug candidates.
• We believe we can better answer the demand for safer, more effective medicines by keeping our sights on both the science and the patient.

Novartis is committed to Innovation worldwide, and especially in the Boston area.  We are offering an in-kind award to the winning pitch that combines a strategic review of the team’s business opportunity with selective access to Novartis resources to help validate the underlying technology.  The strategic business plan review and selective access to resources will be managed out of the business development office at Novartis Institutes for Biomedical Research.  This award will result in a report that the team can use to support fund-raising and commercialization that will provide an analysis of the commercial potential of the opportunity and key milestones that the team needs to hit in the process of commercialization.   It will include a description of the resources that Novartis could deploy to support this commercialization effort and suggestions on whom to contact in the investor community to raise capital.